NCT05514886View on ClinicalTrials.gov

Evaluation of Molecular Point-of-care Xpert® Xpress SARS-CoV-2 Detection Implementation in Resource-limited Settings

CompletedOBSERVATIONAL
Enrollment

3,429

Participants

Timeline

Start Date

August 10, 2022

Primary Completion Date

February 29, 2024

Study Completion Date

February 29, 2024

Conditions
COVID-19
Interventions
DEVICE

Gene Expert molecular Point-of-Care (POC) (Xpert® Xpress SARS-CoV-2/Flu/RSV test

POC viral load (VL) assay in improving the availability of SARS-CoV-2 detection for COVID-19 patient management in decentralized healthcare facilities of resource-constrained settings in Tanzania, DR Congo and Burkina Faso.

Trial Locations (1)

Unknown

Nimr Korogwe, Tanga

All Listed Sponsors
collaborator

University of Kinshasa

OTHER

collaborator

Research Institute for Health Sciences - Burkina Faso

UNKNOWN

collaborator

Universiteit Antwerpen, Belgium

UNKNOWN

collaborator

Københavns Universitet

OTHER

collaborator

Universidad de Valencia, Spain

UNKNOWN

lead

National Institute for Medical Research, Tanzania

OTHER_GOV